AI News NQ Analysis

SS Pharmaceutical Obtains Approval for ED Drug 'Cialis®' as an OTC Medication in Japan

NQ Score 92/100
N1 Content Completeness 9

AI Summary (NQ-processed)

SS Pharmaceutical Co., Ltd. announced that it has obtained manufacturing and marketing approval for the ED treatment drug 'Cialis®' as an over-the-counter (OTC) medication (drug requiring instruction) in Japan for the first time.

AI Analysis

Frequently Asked Questions

Q: Is Cialis® now an over-the-counter drug?
A: Yes, it has been approved as a 'drug requiring instruction,' which allows purchase with pharmacist guidance without a doctor's prescription.
Q: Can anyone buy it immediately?
A: It is for adult males aged 18 and over. A pharmacist's confirmation is required at the time of purchase, and medical consultation may be necessary for those with pre-existing conditions.
Q: When will it be available?
A: It is currently being prepared for launch. Details and launch dates will be announced later.